Transfusion hemosiderosis
Transfusion Hemosiderosis
Transfusion hemosiderosis (pronunciation: trans-fyu-zhun he-mo-si-de-ro-sis) is a medical condition that results from the accumulation of iron in the body due to frequent blood transfusions.
Etymology
The term "transfusion hemosiderosis" is derived from three words: "transfusion", which refers to the process of transferring blood from one person to another; "hemo", a prefix from the Greek word "haima" meaning blood; and "siderosis", from the Greek word "sideros" meaning iron.
Definition
Transfusion hemosiderosis is a form of iron overload that occurs when iron from transfused blood accumulates in the body. This condition is often seen in patients who require frequent blood transfusions, such as those with thalassemia, sickle cell disease, and other chronic anemias.
Symptoms
The symptoms of transfusion hemosiderosis can vary depending on the organs affected by the iron overload. Common symptoms include fatigue, weakness, and an irregular heartbeat. If the condition progresses, it can lead to more serious complications such as heart failure, liver disease, and endocrine disorders.
Treatment
The primary treatment for transfusion hemosiderosis is iron chelation therapy. This involves the use of medications, such as deferasirox and deferoxamine, that bind to excess iron and remove it from the body.
See Also
- Iron Overload
- Blood Transfusion
- Thalassemia
- Sickle Cell Disease
- Heart Failure
- Liver Disease
- Endocrine Disorders
External links
- Medical encyclopedia article on Transfusion hemosiderosis
- Wikipedia's article - Transfusion hemosiderosis
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski